58
Views
264
CrossRef citations to date
0
Altmetric
Reports

Inhibition of tumor Promoter‐induced hydrogen peroxide formation in vitro and in vivo by genistein

, , , &
Pages 1-12 | Received 08 Dec 1992, Accepted 23 Feb 1993, Published online: 04 Aug 2009
 

Abstract

Here we report that genistein, a soybean isoflavone, strongly inhibits tumor promoter‐induced H2O2 formation both in vivo and in vitro. Genistein suppressed H2O2 production by 12‐O‐tetrade‐canoylphorbol‐13‐acetate‐ (TPA) stimulated human polymorphonuclear leukocytes (PMNs) and HL‐60 cells in a dose‐dependent manner over the concentration range 1–150 μM. Human PMNs were more sensitive to the inhibitory effect of genistein than HL‐60 cells (50% inhibitory concentration 14.8 and 30.2 μM, respectively). In addition, genistein moderately inhibited Superoxide anion formation by HL‐60 cells and scavenged exogenously added H2O2 under the same conditions as in cell culture. However, the H2O2‐scavenging effect of genistein was about 50% lower than its inhibition of cell‐derived H2O2 formation at all concentrations. In the CD‐1 mouse skin model, genistein strongly inhibited TPA‐induced oxidant formation, edema, and PMN infiltration in mouse skin. Inhibition of TPA‐mediated H2O2 in vivo may result from decreased cell‐derived H2O2 formation, scavenging of H2O2 produced, and/or suppression of PMN infiltration into the dermis. The antioxidant properties of genistein may be responsible for its anticarcinogenic effects, and the dietary availability of genistein makes it a promising candidate for the prevention of human cancers.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.